Dissection of the NF-κB signalling cascade in transgenic and knockout mice

Studies in transgenic and knockout mice have made a major contribution to our current understanding of the physiological functions of the NF-κB signalling cascade. The generation and analysis of mice with targeted modifications of individual components of the NF-κB pathway tremendously advanced our knowledge of the roles of the NF-κB proteins themselves, and also of the many activators and negative regulators of NF-κB. These studies have highlighted the complexity of the NF-κB system, by revealing the multiple interactions, redundancies, but also diverse functions, performed by the different molecules participating in the regulation of NF-κB signalling. Furthermore, inhibition or enforced activation of NF-κB in transgenic mice has uncovered the critical roles that NF-κB plays in the pathogenesis of various diseases such as liver failure, diabetes and cancer.

[1]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[2]  S. Ley,et al.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. , 2004, The Biochemical journal.

[3]  R. Bolli,et al.  Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha. , 2001, Journal of molecular and cellular cardiology.

[4]  I. Verma,et al.  IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.

[5]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[6]  F. Yull,et al.  Lymphocytes Lacking IκB-α Develop Normally, But Have Selective Defects in Proliferation and Function1 , 2000, The Journal of Immunology.

[7]  S. Akira,et al.  Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.

[8]  Georg Kraal,et al.  Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[9]  M. Karin,et al.  An Essential Role for Nuclear Factor κB in Promoting Double Positive Thymocyte Apoptosis , 1999, The Journal of experimental medicine.

[10]  G. Courtois,et al.  NEMO/IKK gamma-deficient mice model incontinentia pigmenti. , 2000, Molecular cell.

[11]  R. Maehr,et al.  Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Israël,et al.  Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. , 2000, Genes & development.

[13]  M. Boothby,et al.  Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.

[14]  H. Carlsen,et al.  In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.

[15]  R. Flavell,et al.  Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. , 2005, International immunology.

[16]  A. Israël,et al.  Forebrain-Specific Neuronal Inhibition of Nuclear Factor-κB Activity Leads to Loss of Neuroprotection , 2003, The Journal of Neuroscience.

[17]  M. Karin,et al.  The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion , 2003, Nature Medicine.

[18]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[19]  G. Courtois,et al.  Mature T cells depend on signaling through the IKK complex. , 2003, Immunity.

[20]  B. Dörken,et al.  Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. , 2005, Immunity.

[21]  M. T. Hasan,et al.  IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.

[22]  K. Rajewsky,et al.  Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. , 2004, The Journal of clinical investigation.

[23]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[24]  C. Jongeneel,et al.  Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. , 1998, Molecular immunology.

[25]  R. Bravo,et al.  Expression of Constitutively Active IκBβ in T Cells of Transgenic Mice: Persistent NF-κB Activity Is Required for T-Cell Immune Responses , 1998, Molecular and Cellular Biology.

[26]  T. Luedde,et al.  Deletion of IKK 2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia / reperfusion injury , 2005 .

[27]  R. Gaynor,et al.  I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. , 2002, Journal of immunology.

[28]  C. Tato,et al.  Inhibition of NF-κB Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-γ Required for Resistance to Toxoplasma gondii1 , 2003, The Journal of Immunology.

[29]  Steffen Jung,et al.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation , 2000, Nature Medicine.

[30]  M. Karin,et al.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.

[31]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[32]  D. Goeddel,et al.  Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. , 1999, Immunity.

[33]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[34]  D. Brenner,et al.  Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super‐repressor , 1998 .

[35]  H. Edlund,et al.  Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion. , 2005, Diabetes.

[36]  D. F. Barber,et al.  NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. , 2000, Immunity.

[37]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.

[38]  K. Rajewsky,et al.  IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells , 2002, The Journal of experimental medicine.

[39]  Rune Blomhoff,et al.  In vivo imaging of NF-kappa B activity. , 2002, Journal of immunology.

[40]  J. Christman,et al.  Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. , 2000, American journal of respiratory and critical care medicine.

[41]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Fausto,et al.  Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. , 2002, The Journal of clinical investigation.

[43]  T. Leary,et al.  Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality , 1999 .

[44]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[45]  V. Godfrey,et al.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.

[46]  W. Frontera,et al.  IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.

[47]  David Piwnica-Worms,et al.  Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.

[48]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[49]  F. Weih,et al.  Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development , 2003, The Journal of experimental medicine.

[50]  M. Karin,et al.  IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. , 2004, Nature.

[51]  M. Karin,et al.  IKKalpha controls formation of the epidermis independently of NF-kappaB. , 2001, Nature.

[52]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[53]  Richard A. Flavell,et al.  Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000, The Journal of Biological Chemistry.

[54]  F. Weih,et al.  Inhibition of NF‐κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice , 2001, European journal of immunology.

[55]  U. Siebenlist,et al.  Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.

[56]  S. Akira,et al.  Iκb Kinase α Is Essential for Mature B Cell Development and Function , 2001, The Journal of experimental medicine.

[57]  D. Brenner,et al.  Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. , 1998, Hepatology.

[58]  E. Schmidt,et al.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. , 2001, Cell.

[59]  R. Brink,et al.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.

[60]  M. Karin,et al.  IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. , 2003, Immunity.

[61]  Keith W. Jones,et al.  Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α , 2001 .

[62]  M Aguet,et al.  Inducible gene targeting in mice , 1995, Science.

[63]  K. Rajewsky,et al.  Conditional gene targeting. , 1996, The Journal of clinical investigation.

[64]  U. Siebenlist,et al.  Control of lymphocyte development by nuclear factor-kappaB. , 2005, Nature reviews. Immunology.

[65]  P. Khavari,et al.  Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Tato,et al.  Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. , 2003, Journal of immunology.

[67]  R. Gaynor,et al.  I-κB Kinase β Is Critical for B Cell Proliferation and Antibody Response , 2002, The Journal of Immunology.

[68]  N. Perkins Oncogenes, tumor suppressors and p52 NF-κB , 2003, Oncogene.

[69]  A. Hoffmann,et al.  Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. , 2005, Immunity.

[70]  L. Ährlund‐Richter,et al.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. , 1999, Cancer research.

[71]  N. Fausto Liver regeneration. , 2000, Journal of hepatology.

[72]  K. Rajewsky,et al.  IκB Kinase 2 Deficiency in T Cells Leads to Defects in Priming, B Cell Help, Germinal Center Reactions, and Homeostatic Expansion1 , 2004, The Journal of Immunology.

[73]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[74]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[75]  A. Strasser,et al.  The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. , 2003, Seminars in immunology.

[76]  M. Karin,et al.  IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .

[77]  C. Jongeneel,et al.  Abnormal T lymphocyte development induced by targeted overexpression of IkappaB alpha. , 1997, Journal of immunology.

[78]  T. Deerinck,et al.  Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.

[79]  K. Akashi,et al.  Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. , 2003, Immunity.

[80]  R. Gaynor,et al.  I-κB Kinases α and β Have Distinct Roles in Regulating Murine T Cell Function1 , 2002, The Journal of Immunology.

[81]  E. Oltz,et al.  An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets , 1999 .

[82]  L. Moldawer,et al.  LPS-induced liver injury ind-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor , 2000 .

[83]  R. Sherwin,et al.  Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. , 2000, The Journal of biological chemistry.

[84]  David S. Park,et al.  Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival , 2002, The Journal of Neuroscience.

[85]  C. Irvin,et al.  A Prominent Role for Airway Epithelial NF-κB Activation in Lipopolysaccharide-Induced Airway Inflammation1 , 2003, The Journal of Immunology.

[86]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[87]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[88]  M. Karin,et al.  IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.

[89]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[90]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[91]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[92]  D. Brenner,et al.  In Vivo Pattern of Lipopolysaccharide and Anti-CD3-Induced NF-κB Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene Mouse1 , 2004, The Journal of Immunology.

[93]  R. Kühn,et al.  Cre/loxP recombination system and gene targeting. , 2002, Methods in molecular biology.

[94]  M. Karin,et al.  IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. , 2001, Immunity.

[95]  Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. , 2005, The Journal of clinical investigation.

[96]  M. Kay,et al.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors , 1997, Journal of virology.

[97]  A. Strasser,et al.  The role of Rel/NF-κB transcription factors in B lymphocyte survival , 2003 .

[98]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[99]  R. Bravo,et al.  Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ , 1998, The Journal of experimental medicine.

[100]  I. Verma,et al.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.

[101]  B. Ryffel,et al.  Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.

[102]  H. Edlund,et al.  Nuclear Factor-κB Activity in β-Cells Is Required for Glucose-Stimulated Insulin Secretion , 2005 .

[103]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[104]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[105]  T. Wirth,et al.  Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation , 1993, Nature.

[106]  M. Karin,et al.  IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.

[107]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[108]  M. Karin,et al.  IKK beta is required for peripheral B cell survival and proliferation. , 2003, Journal of immunology.

[109]  D. Carrasco,et al.  Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.

[110]  R. Bravo,et al.  Functional Redundancy of the Nuclear Factor k B Inhibitors I k B a and I k B b , 1998 .

[111]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[112]  D. Brenner,et al.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.

[113]  N. Tarantino,et al.  In Vivo Inhibition of NF-κB in T-Lineage Cells Leads to a Dramatic Decrease in Cell Proliferation and Cytokine Production and to Increased Cell Apoptosis in Response to Mitogenic Stimuli, But Not to Abnormal Thymopoiesis , 1999, The Journal of Immunology.

[114]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[115]  E. Oltz,et al.  An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. , 1999, Molecular immunology.

[116]  J. Leiden,et al.  NF-κB Is Required for the Positive Selection of CD8+ Thymocytes1 , 2000, The Journal of Immunology.

[117]  A. Israël,et al.  NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.

[118]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[119]  M. Karin,et al.  IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .

[120]  E. J. Green,et al.  Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.

[121]  M. Karin,et al.  IKKβ Is Required for Peripheral B Cell Survival and Proliferation1 , 2003, The Journal of Immunology.

[122]  M. Leist,et al.  Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.

[123]  F. Yull,et al.  Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function. , 2000, Journal of immunology.

[124]  Tak W. Mak,et al.  The role of nuclear factor-κB essential modulator (NEMO) in B cell development and survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[125]  N. Perkins Oncogenes, tumor suppressors and p52 NF-kappaB. , 2003, Oncogene.

[126]  K. Rajewsky,et al.  Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance , 2004 .

[127]  David S. Park,et al.  Constitutive nuclear factor-kappa B activity is required for central neuron survival. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[128]  M. Matsumoto,et al.  Abnormal Immune Function of Hemopoietic Cells from Alymphoplasia (aly) Mice, a Natural Strain with Mutant NF-κB-Inducing Kinase1 , 2000, The Journal of Immunology.

[129]  C. Galanos,et al.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.

[130]  Klaus Rajewsky,et al.  NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .

[131]  W. Birchmeier,et al.  Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. , 2001, Development.

[132]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[133]  Hideaki Ishikawa,et al.  Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-κB1) but Expressing p50 , 1998, The Journal of experimental medicine.

[134]  B. Dörken,et al.  Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα , 2005 .

[135]  A. Israël,et al.  IκBα/IκBε deficiency reveals that a critical NF-κB dosage is required for lymphocyte survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[136]  A. Israël,et al.  IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival. , 2003, Proceedings of the National Academy of Sciences of the United States of America.